Register Here

2018 Associate Sponsors

Personalis

2018 Media Partners

Life Science Leader
pharmaphorum
SciDoc Publishers
Technology Networks

Who Should Attend

The program is designed for all size pharma/biotech companies and investors seeking to accelerate clinical trials in the emerging immuno-oncology space.

Large Pharma/Biopharma/Biotech responsible for:

  • R&D: Clinical Research/Development, Clinical Operations, Clinical Oncology, Cancer Immunotherapy, Immunology, Translational Research/Development/Medicine, Medical Affairs, R&D Innovation & Strategy, Biomarkers
  • Business Development: Corporate Venture, Licensing, Strategic Partnerships, Negotiations, Early-stage Collaboration, Commercial Innovation, External R&D

Investment Community:

  • Investment Firms
  • Venture Capitals
  • Banks/Financial Institutions
  • Foundation Capital

Academia & Research Organizations focusing on:

  • Immuno-Oncology
  • Immunotherapy
  • Oncology
  • Immunology
  • Immunobiology
  • Cancer Vaccines
  • Adoptive T-Cell Therapy
  • Clinical Research and Development

Solution Providers:

  • CROs
  • Consultants/Advisors
  • Law Firms
  • Technology/Medical Device Platforms

Our audience is as much a part of the event as our speaking faculty. Our ultimate goal is to foster a Summit environment that inspires positive change in immuno-oncology and support for all those involved in the movement. If you are interested in joining the speaking faculty or audience, please email us at Customer Service.